PropertyValue
?:abstract
  • Cancer patients under active chemotherapy are more vulnerable to coronavirus disease 19 (COVID-19). There are still some controversies regarding routine polymerase chain reaction testing of asymptomatic cancer patients before chemotherapy cycles. Despite a lack of data, Al-Shamsi et al. showed higher COVID-19 positivity rate among asymptomatic cancer patients. Furthermore, mortality rate was higher in this group of patients. There is no high evidence-based recommendation from the cancer societies for testing asymptomatic patients before each chemotherapy cycle. In this commentary, we assessed the current publications and guidelines regarding this issue.
?:creator
?:doi
?:doi
  • 10.1177/1078155220988753
?:journal
  • Journal_of_oncology_pharmacy_practice_:_official_publication_of_the_International_Society_of_Oncology_Pharmacy_Practitioners
?:license
  • unk
?:pmid
?:pmid
  • 33470163
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?
?:type
?:year
  • 2021-01-20

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/j1t8ohc1>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/j1t8ohc1>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all